Report Description:

Global Markets Directs, Supernus Pharmaceuticals, Inc. Product Pipeline Review 2015, provides an overview of the Supernus Pharmaceuticals, Inc.s pharmaceutical research and development focus.

This report provides comprehensive information on the current therapeutic developmental pipeline of Supernus Pharmaceuticals, Inc.s, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. It also reviews latest updates, and featured news and press releases, along with special features on late-stage and discontinued projects.

Browse Full Report with Toc Visit:

Global Markets Directs report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Directs proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Directs team. Drug profiles/records featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the latest set of information. Additionally, processes including live news & deals tracking, browser based alert-box and clinical trials registries tracking ensure that the most recent developments are captured on a real time basis.

Browse All Reports Of This Category:

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products.

Latest Reports by Acute Market Reports:


  • The report provides brief overview of Supernus Pharmaceuticals, Inc. including business description, key information and facts, and its locations and subsidiaries
  • The report reviews current pipeline of Supernus Pharmaceuticals, Inc.s human therapeutic division and enlists all their major and minor projects
  • The report features product description and descriptive mechanism of action for key pipeline products along with the products developmental history and major milestones
  • Special feature on out-licensed and partnered product portfolio
  • The report summarizes all the dormant and discontinued pipeline projects
  • Latest company statement
  • Latest news and deals relating to the Supernus Pharmaceuticals, Inc.s pipeline products

Latest Reports: Supernus Pharmaceuticals, Inc. Market to 2015 by Acute Market Reports

Click Here To Download Detail Report:

Reasons to buy:

  • Evaluate Supernus Pharmaceuticals, Inc.s strategic position with total access to detailed information on its product pipeline
  • Assess the growth potential of Supernus Pharmaceuticals, Inc. in its therapy areas of focus
  • Identify new drug targets and therapeutic classes in the Supernus Pharmaceuticals, Inc.s R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas
  • Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps
  • Develop strategic initiatives by understanding the focus areas of Supernus Pharmaceuticals, Inc. and exploit collaboration and partnership opportunities
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Plan mergers and acquisitions effectively by identifying the most promising pipeline of Supernus Pharmaceuticals, Inc.
  • Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope
  • Explore the dormant and discontinued projects of Supernus Pharmaceuticals, Inc. and identify potential opportunities in those areas
  • Avoid Intellectual Property Rights related issues

Table of Contents 2

List of Tables 3

List of Figures 3

Supernus Pharmaceuticals, Inc. Snapshot 4

Supernus Pharmaceuticals, Inc. Overview 4

Key Information 4

Key Facts 4

Supernus Pharmaceuticals, Inc. – Research and Development Overview 5

Key Therapeutic Areas 5

Supernus Pharmaceuticals, Inc. – Pipeline Review 7

Pipeline Products by Stage of Development 7

Pipeline Products – Monotherapy 8

Supernus Pharmaceuticals, Inc. – Pipeline Products Glance 9

Supernus Pharmaceuticals, Inc. – Clinical Stage Pipeline Products 9

Phase II Products/Combination Treatment Modalities 9

Supernus Pharmaceuticals, Inc. – Early Stage Pipeline Products 10

IND/CTA Filed Products/Combination Treatment Modalities 10

Supernus Pharmaceuticals, Inc. – Drug Profiles 11

molindone hydrochloride ER 11

Product Description 11

Mechanism of Action 11

R&D Progress 11

viloxazine hydrochloride 12

Product Description 12

All Reports Of This Publisher:

About Acute Market Reports:

Acute Market Reports is the most sufficient collection of market intelligence services online. It is your only source that can fulfill all your market research requirements.  We provide online reports from over 100 best publishers and upgrade our collection regularly to offer you direct online access to the world’s most comprehensive and recent database with expert perceptions on worldwide industries, products, establishments and trends. Our database consists of 200,000+ market research reports with detailed & minute market research.

Contact Us:
Chris Paul
Sales Manager
Office No 101, 1st Floor,
Aditi Mall, Baner,
Pune, MH, 411045
Toll Free(US/CANADA): +1-855-455-8662
India: +91 7755981103
Web: AcuteMarketReports